Initiation of Phase 1/2 combination trial with PYX-201, an extracellular ADC targeting Extradomain-B Fibronectin (EDB+FN) and Merck’s KEYTRUDA® ...

Pyxis Oncology (PYXS) announced significant progress in its clinical program for PYX-201, a first-in-concept antibody-drug conjugate, ADC, that ...

Announcing a new publication for Acta Materia Medica journal. Single-cell RNA sequencing (scRNA-seq) data from published datasets were obtained to investigate the expression and dysregulation of ...

Scientist Sarallah Rezazadeh from the Icahn School of Medicine explores the molecular mechanisms behind adult stem cells as ...

Announcing a new publication for Acta Materia Medica journal. Single-cell RNA sequencing (scRNA-seq) data from published datasets were obtained to investigate the expression and dysregulation of ...

Hologic, Inc. (NASDAQ:HOLX – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Thursday after Leerink Partnrs downgraded the stock from a strong-buy rating to a hold ...

Novel Peptide Shows Promise for the Treatment of Severe Burns STONY BROOK, NY, UNITED STATES, February 5, 2025 /EINPresswire / -- Neomatrix Th ...

Single-cell RNA sequencing (scRNA-seq) data from published datasets were obtained to investigate the expression and ...